![Jonathan Wygant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Wygant
Comptroller/Controller/Auditor bei
VERACYTE, INC.
Vermögen: 2 Mio $ am 30.09.2026
Profil
Jonathan Wygant is currently Chief Accounting Officer & Vice President at Veracyte, Inc. since 2022.
Formerly, Mr. Wygant was Finance Director-Medical Products Segment at Cardinal Health, Inc., Chief Accounting Officer, SVP-Finance & Controller at Alere, Inc. from 2016 to 2017, Finance Manager at CareFusion 303, Inc. in 2004, Senior Auditor at PricewaterhouseCoopers LLP, Chief Accounting Officer, Senior VP & Controller at CareFusion Corp.
from 2009 to 2016, Chief Accounting Officer, VP & Controller at Cibus Corp.
from 2018 to 2020, Chief Accounting Officer at Cibus Ltd. from 2018 to 2020, and Controller at Biosplice Therapeutics, Inc. Education includes undergraduate studies at the University of San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VERACYTE, INC. 0.05% | 28.10.2026 | 41’920 ( 0.05% ) | 2 Mio $ | 30.09.2026 |
Aktive Positionen von Jonathan Wygant
| Unternehmen | Position | Beginn |
|---|---|---|
| VERACYTE, INC. | Comptroller/Controller/Auditor | 22.02.2022 |
Ehemalige bekannte Positionen von Jonathan Wygant
| Unternehmen | Position | Ende |
|---|---|---|
| CALYXT, INC. | Finanzdirektor/CFO | - |
Cibus Ltd.
 Cibus Ltd. BiotechnologyHealth Technology Engages in the research and development of plant gene editing technology | Comptroller/Controller/Auditor | 01.10.2020 |
| ALERE INC | Finanzdirektor/CFO | 01.10.2017 |
| CAREFUSION CORPORATION | Comptroller/Controller/Auditor | 01.01.2016 |
CareFusion 303, Inc.
 CareFusion 303, Inc. Medical SpecialtiesHealth Technology Designs, makes and distributes infusion therapy and vital signs measurement instruments | Corporate Officer/Principal | 01.07.2004 |
Ausbildung von Jonathan Wygant
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Cardinal Health, Inc.
 Cardinal Health, Inc. Medical DistributorsDistribution Services Distributes pharmaceuticals and engages in manufacturing & sale of medical, surgical and laboratory supplies | Distribution Services |
Alere, Inc.
 Alere, Inc. Medical SpecialtiesHealth Technology Manufactures point-of-care diagnostic tests | Health Technology |
CareFusion 303, Inc.
CareFusion 303, Inc. Medical SpecialtiesHealth Technology Designs, makes and distributes infusion therapy and vital signs measurement instruments | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
Veracyte, Inc.
 Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
CareFusion Corp.
 CareFusion Corp. Medical SpecialtiesHealth Technology Manufactures and distributes medical supplies | Health Technology |
Cibus Corp.
 Cibus Corp. BiotechnologyHealth Technology Operates as an agricultural technology company that develops gene edited plant traits | Health Technology |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cibus Ltd.
Cibus Ltd. BiotechnologyHealth Technology Engages in the research and development of plant gene editing technology | Health Technology |
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. BiotechnologyHealth Technology Operates as a pre-clinical research company that develops small-molecule therapeutics for osteoarthritis & cancer | Health Technology |
